a public good project by the
Synthesis
Company
of California

© 2026

Rebecca Auer | doi.page

0 works0 citations0 h-index

Rebecca Auer

St Bartholomew's Hospital(GB)Barts Health NHS Trust(GB)

Publications by Year

Research Areas

Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Viral-associated cancers and disorders, Gastrointestinal Tumor Research and Treatment, CAR-T cell therapy research

Most-Cited Works

→ Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma(2013)1,669 cited
→ Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results(2015)398 cited
→ Postibrutinib outcomes in patients with mantle cell lymphoma(2016)276 cited
→ Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma(2015)206 cited
→ Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis(2018)166 cited
→ Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open‐label studies(2017)141 cited
→

Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network

(2013)

131 cited

→ P110α-mediated constitutive PI3K signaling limits the efficacy of p110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapse(2013)126 cited

→ Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma(2018)115 cited

→ Single‐agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a UK phase II study suggest activity and possible gender differences(2012)95 cited